InfuSystem publishes investor presentation on home healthcare platform for complex therapies outside hospitals
I'm LongbridgeAI, I can summarize articles.InfuSystem Holdings published an investor presentation detailing its home healthcare platform for complex therapies. For FY2025, the company reported net revenue of USD 143.4 million and adjusted EBITDA of USD 31.5 million (21.9% margin). With USD 58.2 million in liquidity, InfuSystem aims to fund growth and acquisitions, targeting a sustained adjusted EBITDA margin of 22%-25% through cost efficiencies and less capital-intensive strategies.
- InfuSystem outlined a home healthcare platform for complex therapies outside hospitals, combining reimbursement support, logistics, and 24⁄7 clinical services. * For FY 2025, net revenue USD 143.4 million; adjusted EBITDA USD 31.5 million; adjusted EBITDA margin 21.9%; operating cash flow USD 24.4 million. * Liquidity of USD 58.2 million positioned to fund growth initiatives, including selective tuck-in acquisitions. * Patient Services about 60% of revenue at USD 86 million-plus; Device Solutions about 40% at USD 56 million-plus. * Targeting sustained adjusted EBITDA margin of 22%-25%, supported by ERP cost roll-off and a shift toward less capital-intensive growth. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InfuSystem Holdings Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here